FGF23 and Osteopenia: Altered human KL expression is related to osteopenia/osteoporosis5, suppression of Wnt signaling6, amelioration of vascular endothelial dysfunction7, and in mediating the role of fibroblast growth factor 23 (FGF23) in bone-kidney-parathyroid control of phosphate and calcium8.